Page 19 - Expanded Access Program News Today

/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that members of its...

/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that members of its...

Press release content from Accesswire. The AP news staff was not involved in its creation.

RALEIGH, NC and TEL-AVIV, ISRAEL / ACCESSWIRE / December 15, 2021 / RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that members

Investegate announcements from RedHill Biopharma, RedHill Announces Additional Insider Buying

Humacyte Announces Publication Highlighting the First Use of the Human Acellular Vessel (HAV™) as Arterial Bypass Conduit for Replacement of Infected Prosthetic Graft - read this article along with other careers information, tips and advice on BioSpace

RedHill Biopharma: Concerning Rates of Clarithromycin Prescribing for H. pylori, Despite Increasing Antibiotic Resistance, Uncovered in New Digestive Diseases & Sciences Publication - read this article along with other careers information, tips and advice on BioSpace

RedHill Biopharma Ltd Announces Concerning Clarithromycin Rx Rates for H. pylori - read this article along with other careers information, tips and advice on BioSpace

Investegate announcements from RedHill Biopharma, Concerning Clarithromycin Rx Rates for H. pylori

Unique Mode of Action Opaganib works by targeting the human host cell rather than the virus itself and is therefore not expected to be impacted by spike...